Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: A meta-analysis of clinical trials 3 Z$ N5 n5 n6 e' s* g( l; Ahttp://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=3ElacPLA2LMG1368EmG&page=1&doc=3
发表于 2012-2-14 14:37
